HeartBeam, Inc. (BEAT)

Market Cap	46.84M -31.2%
Revenue (ttm)	n/a
Net Income	-21.02M
EPS	-0.62
Shares Out	41.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	516,861
Open	1.120
Previous Close	1.090
Day's Range	1.100 - 1.180
52-Week Range	0.540 - 4.000
Beta	-0.80
Analysts	Strong Buy
Price Target	6.17 (+441.23%)
Earnings Date	Mar 12, 2026

About BEAT

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician port...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 16
• Stock Exchange: NASDAQ
• Ticker Symbol: BEAT
• Website: https://www.heartbeam.com

Analyst Summary

According to 3 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price target is $6.17, which is an increase of 441.23% from the latest price.

Price Target

$6.17

(441.23% upside)

Analyst Consensus: Strong Buy